CN101360485A - 作为胶囊填充物的基于亲水性载体的双重控释基质系统 - Google Patents
作为胶囊填充物的基于亲水性载体的双重控释基质系统 Download PDFInfo
- Publication number
- CN101360485A CN101360485A CNA2006800457275A CN200680045727A CN101360485A CN 101360485 A CN101360485 A CN 101360485A CN A2006800457275 A CNA2006800457275 A CN A2006800457275A CN 200680045727 A CN200680045727 A CN 200680045727A CN 101360485 A CN101360485 A CN 101360485A
- Authority
- CN
- China
- Prior art keywords
- substrate
- weight
- agent
- hydrogel
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Abstract
Description
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73040605P | 2005-10-26 | 2005-10-26 | |
US60/730,406 | 2005-10-26 | ||
PCT/US2006/042177 WO2007050975A2 (en) | 2005-10-26 | 2006-10-26 | Hydrophilic vehicle-based dual controlled release matrix system as capsule fill |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101360485A true CN101360485A (zh) | 2009-02-04 |
CN101360485B CN101360485B (zh) | 2013-04-17 |
Family
ID=37801480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800457275A Expired - Fee Related CN101360485B (zh) | 2005-10-26 | 2006-10-26 | 作为胶囊填充物的基于亲水性载体的双重控释基质系统 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8333989B2 (zh) |
EP (1) | EP1959935A2 (zh) |
JP (2) | JP5406530B2 (zh) |
CN (1) | CN101360485B (zh) |
CA (1) | CA2627292C (zh) |
WO (1) | WO2007050975A2 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101485707B (zh) * | 2009-02-23 | 2011-05-18 | 四川珍珠制药有限公司 | 一种灵丹草软胶囊及其制备方法 |
CN101491549B (zh) * | 2009-02-23 | 2011-08-03 | 四川珍珠制药有限公司 | 一种中药软胶囊及其制备方法 |
CN105307634A (zh) * | 2013-03-15 | 2016-02-03 | 沃纳奇尔科特有限责任公司 | 含有改性瓜尔胶的药物软明胶胶囊剂型 |
CN105392476A (zh) * | 2013-03-15 | 2016-03-09 | 沃纳奇尔科特有限责任公司 | 药物软明胶胶囊剂型 |
CN110234354A (zh) * | 2017-01-24 | 2019-09-13 | 雀巢产品有限公司 | 包含抗-fel d1抗体的组合物和用于减少人类对猫的过敏症的至少一种症状的方法 |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1553927T1 (sl) * | 2002-09-11 | 2010-12-31 | Elan Pharma Int Ltd | Z gelom stabilizirani nanodeläśni sestavki uäśinkovine |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
DK3095447T3 (da) | 2006-02-03 | 2022-01-31 | Opko Renal Llc | Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3 |
HUE037309T2 (hu) | 2006-06-21 | 2018-08-28 | Opko Ireland Global Holdings Ltd | Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer |
KR20190028822A (ko) | 2007-04-25 | 2019-03-19 | 사이토크로마 인코포레이티드 | 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물 |
CA2683514C (en) | 2007-04-25 | 2019-07-09 | Proventiv Therapeutics, Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
CN104257667B (zh) | 2007-04-25 | 2019-06-04 | 欧普科Ip 控股Ii 有限公司 | 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物 |
BRPI0811319A2 (pt) | 2007-05-25 | 2015-02-10 | Tolmar Therapeutics Inc | Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento |
EP2281058B1 (en) | 2008-04-02 | 2016-06-29 | Opko Ireland Global Holdings, Ltd. | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
WO2011123476A1 (en) | 2010-03-29 | 2011-10-06 | Cytochroma Inc. | Methods and compositions for reducing parathyroid levels |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US20150250750A1 (en) * | 2012-10-16 | 2015-09-10 | Wockhardt Limited | Pharmaceutical compostions of diclofenac or salts thereof |
US20150238451A1 (en) * | 2012-10-19 | 2015-08-27 | Wockhardt Limited | Pharmaceutical compositions of diclofenac or salts thereof |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
US10420729B2 (en) | 2013-03-15 | 2019-09-24 | R.P. Scherer Technologies, Llc | Abuse resistant capsule |
JP6539274B2 (ja) | 2013-08-12 | 2019-07-03 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 押出成形された即放性乱用抑止性丸剤 |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10098863B2 (en) | 2014-02-28 | 2018-10-16 | Banner Life Sciences Llc | Fumarate esters |
EP3501510B1 (en) | 2014-02-28 | 2020-07-01 | Banner Life Sciences LLC | Controlled release enteric soft capsules of fumarate esters |
US9326947B1 (en) | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
US9636318B2 (en) | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
US10772842B2 (en) | 2015-01-09 | 2020-09-15 | Patheon Softgels Inc. | Abuse-deterrent opioids |
US10182992B2 (en) | 2014-04-07 | 2019-01-22 | Patheon Softgels Inc. | Abuse-deterrent controlled release formulations |
JP6371463B2 (ja) | 2014-07-17 | 2018-08-08 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 即時放出性乱用抑止性液体充填剤形 |
EP3193925A2 (en) | 2014-08-07 | 2017-07-26 | OPKO Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin d |
US20160106737A1 (en) | 2014-10-20 | 2016-04-21 | Pharmaceutical Manufacturing Research Services, Inc. | Extended Release Abuse Deterrent Liquid Fill Dosage Form |
CA2978269A1 (en) * | 2015-03-02 | 2016-09-09 | Bionpharma Healthcare Llc | Immediate release soluble ibuprofen compositions |
KR20230054752A (ko) | 2016-03-28 | 2023-04-25 | 옵코 아일랜드 글로벌 홀딩스 리미티드 | 비타민 d 치료 방법 |
US11903918B2 (en) | 2020-01-10 | 2024-02-20 | Banner Life Sciences Llc | Fumarate ester dosage forms with enhanced gastrointestinal tolerability |
MX2023004441A (es) * | 2020-10-16 | 2023-05-08 | Scherer Technologies Llc R P | Composiciones de relleno de liberacion controlada y capsulas que las contienen. |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947600A (en) * | 1973-10-12 | 1976-03-30 | General Foods Corporation | Dipeptide sweetening of comestibles |
US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
BE1003009A5 (fr) * | 1989-02-09 | 1991-10-22 | Sandoz Sa | Nouvelles compositions pharmaceutiques a base de cyclosporines. |
JPH0717498B2 (ja) * | 1989-05-31 | 1995-03-01 | 興和株式会社 | 鎮咳去痰ソフトカプセル剤 |
CA2017916C (en) * | 1989-06-07 | 1999-02-02 | Minoru Aoki | Etoposide preparations |
DE69226950T2 (de) * | 1991-04-08 | 1999-05-12 | Nippon Shinyaku Co Ltd | Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt |
US5505961A (en) * | 1993-08-05 | 1996-04-09 | R. P. Scherer Corporation | Gelatin capsules containing a highly concentrated acetaminophen solution |
GB9322314D0 (en) | 1993-10-29 | 1993-12-15 | Scherer Ltd R P | Foam generating capsules |
CA2181241C (en) * | 1994-01-24 | 2000-04-25 | Dadi Jamshed Dhabhar | Process for solubilizing difficultly soluble pharmaceutical actives |
US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
US5641512A (en) * | 1995-03-29 | 1997-06-24 | The Procter & Gamble Company | Soft gelatin capsule compositions |
FR2748209B1 (fr) | 1996-05-06 | 1998-06-05 | Adir | Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs |
US6027746A (en) * | 1997-04-23 | 2000-02-22 | Warner-Lambert Company | Chewable soft gelatin-encapsulated pharmaceutical adsorbates |
BE1011363A3 (fr) * | 1997-09-11 | 1999-08-03 | Smb Technology | Capsules semi-solides autoemulsionnables matricielles a action prolongee. |
GB2331458B (en) | 1997-11-21 | 2002-07-31 | Gursharan Singh Moonga | Solubilising systems for difficult pharmaceutical actives for preparing concentrated stable solutions for encapsulation into soft gelatine |
EP1049459B1 (en) * | 1998-01-20 | 2009-04-22 | Applied Analytical Industries, Inc. | Oral liquid compositions |
US6365180B1 (en) * | 1998-01-20 | 2002-04-02 | Glenn A. Meyer | Oral liquid compositions |
FR2782006B1 (fr) * | 1998-08-07 | 2002-04-19 | Gattefosse Ets Sa | Composition a liberation prolongee apte a former une micro-emulsion |
US6251426B1 (en) * | 1999-09-02 | 2001-06-26 | Banner Pharmacaps, Inc. | Ibuprofen-containing softgels |
MXPA02003190A (es) * | 1999-09-27 | 2002-09-30 | American Cyanamid Co | Formulacion para portadores farmaceuticos. |
DE60028754T2 (de) * | 1999-11-12 | 2007-05-31 | Abbott Laboratories, Abbott Park | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
US6607736B2 (en) * | 1999-12-20 | 2003-08-19 | Shiseido Company, Ltd. | Skin preparations for external use |
US6491950B1 (en) | 2000-08-07 | 2002-12-10 | Kos Pharmaceuticals, Inc. | Controlled release pharmaceutical composition |
US6524615B2 (en) * | 2001-02-21 | 2003-02-25 | Kos Pharmaceuticals, Incorporated | Controlled release pharmaceutical composition |
US20030105141A1 (en) * | 2001-04-17 | 2003-06-05 | Ping Gao | Finely self-emulsifiable pharmaceutical composition |
JP2003055254A (ja) * | 2001-08-17 | 2003-02-26 | Toyo Capsule Kk | 経口投与用シクロスポリン製剤 |
US7029698B2 (en) * | 2001-11-21 | 2006-04-18 | R.P. Scherer Technologies, Inc. | Acetaminophen compositions |
WO2003061626A1 (en) * | 2002-01-18 | 2003-07-31 | Control Delivery Systems, Inc. | Polymeric gel system for the controlled delivery of codrugs |
IL164163A0 (en) * | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
FR2838349B1 (fr) * | 2002-04-15 | 2004-06-25 | Laurence Paris | Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication |
US20040033257A1 (en) * | 2002-05-30 | 2004-02-19 | Strides Inc. | Pharmaceutical formulation in a drug delivery system and process for preparing the same |
WO2004004693A1 (en) * | 2002-07-05 | 2004-01-15 | Collgegium Pharmaceutical | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
PT2772250T (pt) | 2002-10-01 | 2017-01-02 | Banner Life Sciences Llc | Composição entérica para o fabrico de uma parede de cápsula mole |
ES2592504T3 (es) | 2003-07-17 | 2016-11-30 | Banner Life Sciences, LLC | Preparaciones de liberación controlada |
US20050096365A1 (en) | 2003-11-03 | 2005-05-05 | David Fikstad | Pharmaceutical compositions with synchronized solubilizer release |
WO2005070399A1 (en) * | 2004-01-09 | 2005-08-04 | Wyeth | Microemulsions for pharmaceutical compositions |
WO2006133048A2 (en) * | 2005-06-03 | 2006-12-14 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same |
-
2006
- 2006-10-26 CA CA2627292A patent/CA2627292C/en not_active Expired - Fee Related
- 2006-10-26 EP EP06826983A patent/EP1959935A2/en not_active Withdrawn
- 2006-10-26 WO PCT/US2006/042177 patent/WO2007050975A2/en active Application Filing
- 2006-10-26 JP JP2008538048A patent/JP5406530B2/ja not_active Expired - Fee Related
- 2006-10-26 CN CN2006800457275A patent/CN101360485B/zh not_active Expired - Fee Related
- 2006-10-26 US US11/553,356 patent/US8333989B2/en not_active Expired - Fee Related
-
2013
- 2013-06-26 JP JP2013133677A patent/JP2013216680A/ja active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101485707B (zh) * | 2009-02-23 | 2011-05-18 | 四川珍珠制药有限公司 | 一种灵丹草软胶囊及其制备方法 |
CN101491549B (zh) * | 2009-02-23 | 2011-08-03 | 四川珍珠制药有限公司 | 一种中药软胶囊及其制备方法 |
CN105307634A (zh) * | 2013-03-15 | 2016-02-03 | 沃纳奇尔科特有限责任公司 | 含有改性瓜尔胶的药物软明胶胶囊剂型 |
CN105392476A (zh) * | 2013-03-15 | 2016-03-09 | 沃纳奇尔科特有限责任公司 | 药物软明胶胶囊剂型 |
CN105392476B (zh) * | 2013-03-15 | 2018-11-02 | 沃纳奇尔科特有限责任公司 | 药物软明胶胶囊剂型 |
CN105307634B (zh) * | 2013-03-15 | 2020-03-10 | 沃纳奇尔科特有限责任公司 | 含有改性瓜尔胶的药物软明胶胶囊剂型 |
CN110234354A (zh) * | 2017-01-24 | 2019-09-13 | 雀巢产品有限公司 | 包含抗-fel d1抗体的组合物和用于减少人类对猫的过敏症的至少一种症状的方法 |
CN110234354B (zh) * | 2017-01-24 | 2023-09-12 | 雀巢产品有限公司 | 包含抗-fel d1抗体的组合物和用于减少人类对猫的过敏症的至少一种症状的方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2627292C (en) | 2012-04-17 |
CA2627292A1 (en) | 2007-05-03 |
EP1959935A2 (en) | 2008-08-27 |
US20070098783A1 (en) | 2007-05-03 |
WO2007050975A2 (en) | 2007-05-03 |
WO2007050975A3 (en) | 2007-09-20 |
US8333989B2 (en) | 2012-12-18 |
CN101360485B (zh) | 2013-04-17 |
JP2013216680A (ja) | 2013-10-24 |
JP5406530B2 (ja) | 2014-02-05 |
JP2009513669A (ja) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101360485B (zh) | 作为胶囊填充物的基于亲水性载体的双重控释基质系统 | |
CN101351196B (zh) | 作为胶囊填充物的基于亲脂性载体的双重控释基质系统 | |
US20150250733A1 (en) | Oral drug delivery formulations | |
US20040157928A1 (en) | Solvent system of hardly soluble drug with improved dissolution rate | |
US20090318558A1 (en) | Solvent system of hardly soluble drug with improved dissolution rate | |
IL198225A (en) | Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability | |
WO2009066146A2 (en) | Stable solutions of sparingly soluble actives | |
JP2015071612A (ja) | 乱用可能性が低減された医薬組成物 | |
CN1972666A (zh) | 用于活性物质控释给药的oros推动-突出系统 | |
CN102697704A (zh) | 阿片类与非阿片类镇痛药的控释制剂 | |
US20130011470A1 (en) | Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof | |
CN1159754A (zh) | 改进的含有布洛芬和可待因的药物配方 | |
EP1684732A2 (en) | Ibuprofen-containing soft gelatin capsules | |
KR100612070B1 (ko) | 용출률이 향상된 난용성 약제의 용매 시스템 및 이를 함유한 제약학적 제제 | |
WO2016084099A1 (en) | Soft gelatin capsule composition of anti-tussive agents | |
US20240066028A1 (en) | Compositions for improved delivery of cgrp inhibitors | |
MX2008005474A (en) | Hydrophilic vehicle-based dual controlled release matrix system as capsule fill | |
TWM511327U (zh) | 正壓膠囊 | |
TW201705931A (zh) | 正壓膠囊及其製造方法 | |
MX2008005470A (en) | Lipophilic vehicle-based dual controlled release matrix system as capsule fill |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: BANNER LIFE SCIENCES INC. Free format text: FORMER NAME: BANNER PHARMACAPS INC. |
|
CP01 | Change in the name or title of a patent holder |
Address after: North Carolina Patentee after: Banner Pharmacaps Inc Address before: North Carolina Patentee before: Banner Pharmacaps Inc |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170920 Address after: North Carolina Patentee after: Pasin Rubber Company Address before: North Carolina Patentee before: Banner Pharmacaps Inc |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130417 Termination date: 20191026 |
|
CF01 | Termination of patent right due to non-payment of annual fee |